Hospital for Special Surgery, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hospital for Special Surgery, New York sits in the top decile of US sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count).
Hospital for Special Surgery, New York: 194 sponsored US clinical trials, 35 recruiting.
Hospital for Special Surgery, New York sponsors 194 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 123 completed. 58 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 7 trials.
Top-decile sponsor footprint
Hospital for Special Surgery, New York ranks in the top decile of sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 145 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
194 total, page 3 of 4
Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia
NCT03021096
IV vs Oral Acetaminophen in Spine Fusion Perioperative Care
NCT03020875
Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery.
NCT02996591
Enhanced Recovery After Spine Surgery
NCT02949518
Shared Decision Making and How It Impacts the Patient Understanding
NCT04011488
Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy
NCT02688530
Imaging Biomarkers in Crohn's Associated Spondyloarthritis
NCT02709694
Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty
NCT02926235
Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes
NCT02700451
Audiovisual Aid Pilot Study
NCT02506673
Personalized Back Rx Exercise Program as a Treatment for Discogenic Low Back Pain
NCT03040310
Persistent Postoperative Pain and Joint Stiffness After Total Knee Arthroplasty Performed for Osteoarthritis
NCT02626533
Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia
NCT02602080
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
NCT02626845
Anticipated Versus Actual Patient and Caregiver Burden Following Ambulatory Orthopedic Surgery
NCT02550886
Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement
NCT02540226
A Novel Method for Capturing the Visual Evoked Potential During Spine Surgery Under Total Intravenous Anesthesia
NCT02563028
Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy
NCT02506660
A Randomized Controlled Trial of Leg Length Discrepancy Techniques
NCT02260856
The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO
NCT02257580
Volar Plate vs. Conventus DRS Fixation
NCT02390856
Implementation of Pedometer for Monitoring Step Count Pre and Post Lumbar ESI for Radicular Pain
NCT02356783
A Hemodynamic Comparison of Stationary and Portable Pneumatic Compression Devices
NCT02345642
A Pilot Study of Biomarkers in Obstructive Sleep Apnea
NCT02325687
Consortium of Early Arthritis Cohorts USA
NCT02386527
Cerebral Oxygenation in Total Hip Arthroplasty Patients
NCT02325154
Longitudinal Evaluation of Hip Cartilage Degeneration: FAI
NCT02408276
Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis
NCT02984228
The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)
NCT02292082
Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy
NCT02253810
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
NCT02197065
Total Shoulder Arthroplasty Near-infrared Spectroscopy
NCT02198183
Does Chewing Gum Hasten Return of Bowel Function Post-Operatively in Patients Undergoing Spinal Surgery
NCT02186717
An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty
NCT02154243
Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia
NCT02148809
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
NCT02094352
Total Knee Arthroplasty Utilizing Adductor Canal Block: Effect on Quadriceps Sparing
NCT02081911
The Effect of Hypotensive Anesthesia on Hemoglobin Levels During Total Knee Arthroplasty
NCT05340751
Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?
NCT02005601
Perioperative Flare in RA: Characterization of Clinical and Biological Features
NCT02111057
Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy
NCT02978833
The Knee Usual Care Evaluation Study
NCT01905358
Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical
NCT01940523
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
NCT01784523
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
NCT01969188
Trial of Asthma Self-Management Education in Patients With Depressive Symptoms
NCT01708070
Analgesia After Total Shoulder Arthroplasty
NCT01782872
Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery
NCT01782859
Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)
NCT02198235
Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
NCT01833598
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 14 |
| Phase 3 | 8 |
| Phase 4 | 50 |
Therapeutic Areas
Where Hospital for Special Surgery, New York enrollment is open (later-stage tilt)
35 recruiting of 194 indexed (18% open); 123 completed (63%).
Phase mix: 58 late (III/IV) vs 19 early (I/II) (later-stage heavy).
Top condition: Opioid Use (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hospital for Special Surgery, New York: open-pipeline peers nationwide
Peers matched on 194 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Hospital for Special Surgery, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 194 trials (± recruiting share)
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- Vertex Pharmaceuticals Incorporated · 191 trials · 10% recruiting
- Vanderbilt-Ingram Cancer Center · 189 trials · 15% recruiting
- Nationwide Children's Hospital · 188 trials · 15% recruiting
Sponsors near 18% open enrollment (± trial volume)
- George Washington University · 18% recruiting · 133 trials
- West Virginia University · 18% recruiting · 122 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this Hospital for Special Surgery, New York page
194 registered trials is a research-attention snapshot, not an endorsement of Hospital for Special Surgery, New York or any single study.
- 35 of Hospital for Special Surgery, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use is the condition Hospital for Special Surgery, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hospital for Special Surgery, New York pipeline card: 194 registered trials from official public datasets.Report a data error.